Stephanie Davis
Stock Analyst at Barclays
(0)
# 4918
Out of 5,370 analysts
163
Total ratings
33.33%
Success rate
-23.16%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
DGX Quest Diagnostics | Maintains: Equal-Weight | 175 185 | 179.91 | 2.83% | 5 | Apr 23, 2025 | |
WAY Waystar Holding | Maintains: Overweight | 50 45 | 38.53 | 16.79% | 3 | Apr 14, 2025 | |
OPRX OptimizeRx | Maintains: Equal-Weight | 11 5 | 13.65 | -63.37% | 3 | Nov 14, 2024 | |
DOCS Doximity | Maintains: Overweight | 52 75 | 56.32 | 33.17% | 5 | Nov 11, 2024 | |
LFST LifeStance Health Gr | Maintains: Underweight | 6 7 | 5.1 | 37.25% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 10 6 | 4.47 | 34.23% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 39 19 | 8.23 | 130.86% | 1 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 263 290 | 292.81 | -0.96% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 20 24 | 22.2 | 8.11% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 117 133 | 163.04 | -18.42% | 2 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 39 58 | 28.91 | 100.62% | 2 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 2 3 | 2.83 | 6.01% | 7 | Oct 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 1 1 | n/a | n/a | 3 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 6 5 | n/a | n/a | 10 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 213 249 | 262.18 | -5.03% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 14 14 | n/a | n/a | 6 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 12 10 | n/a | n/a | 6 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 29 | 24.96 | 16.19% | 11 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 11 | n/a | n/a | 10 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 34 | 6.96 | 388.51% | 9 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 59 34 | 20.95 | 62.29% | 3 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 242 233 | 280.55 | -16.95% | 9 | Dec 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 20 17 | 3.77 | 350.93% | 10 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 25 | n/a | n/a | 6 | Oct 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 67 76 | 98.76 | -23.05% | 5 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 11 4 | n/a | n/a | 7 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 88 95 | n/a | n/a | 4 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 34 36 | n/a | n/a | 4 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 45 41 | 31.86 | 28.69% | 4 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 60 56 | n/a | n/a | 7 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 55 53 | n/a | n/a | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 31 35 | n/a | n/a | 2 | Aug 10, 2020 |